Helio Health Funding, Investors & Competitors

Helio Health has raised $148M across 2 funding rounds, most recently a $118M Series B in July 2021.

Last Helio Health funding round

$118M

Series B · Jul 2021

Cumulative funding Helio Health raised

$148M

across 2 funding rounds

Key investors in Helio Health

Helio Health Overview

About Helio Health

Helio Health is an Irvine, California-headquartered diagnostics company commercializing AI-analyzed blood tests for early detection of liver, colon, breast, and lung cancers. It operates CLIA-certified labs in Irvine and West Lafayette, Indiana, providing physicians with actionable insights from liquid biopsies.


Founded

2014

HQ

United StatesLos Angeles, CA

Status

Privately held

Customer focus

B2B

Revenue model

Services, Subscription

Helio Health Funding History

Helio Health has raised a total of $148M across 2 funding rounds.

Helio Health's first fundraising round was a $30M Series A in January 2017. The most recent completed round was a $118M Series B in July 2021.

Helio Health funding rounds

Helio Health funding rounds
DateStageInvestorsRaisedDeal Summary
Jul 2021Series BFulgent Genetics (lead); Samsung Securities (lead)$118MHelio Health, operating as Helio Genomics, is an AI-driven healthcare company focused on early cancer detection through blood tests using a multi-modal, multi-omics approach to biomarker discovery for improved medical decision-making. Another round occurred on June 19, 2024, as a Spinoff/Spinout involving Laboratory for Advanced Medicine.
Jan 2017Series A-$30MHelio Health is a nonprofit organization based in Syracuse, New York, providing behavioral health services including outpatient mental health and substance use treatment, screening, assessment, primary care monitoring, targeted case management, psychiatric rehabilitation, and peer support. In 2017, it received designation as one of only 13 Certified Community Behavioral Health Clinics (CCBHCs) in New York State, aimed at enhancing care coordination for individuals with serious mental illnesses and addictions, serving both adults and children. The organization offers programs like K.E.E.S. (Keys to Employment and Economic Stability), established in 2008, to support residential services for economic self-sufficiency and community reintegration, particularly for high-cost Medicaid users to reduce costs and promote recovery. For the fiscal year ending in 2017, Helio Health reported total revenue of $29,535,750, with program services contributing $19,340,722 (65.5%) and contributions $9,049,334 (30.6%), alongside minor investment income. Expenses totaled $27,601,854, resulting in net income of $1,933,896. Helio Health operates extensive services focused on addiction recovery and mental health, with patient testimonials highlighting life-changing impacts through provided tools for joy, love, and effective challenge management.

Who has invested in Helio Health?

2 investors have backed Helio Health across its funding rounds, including Samsung Securities and Fulgent Genetics.

Lead investors include Fulgent Genetics and Samsung Securities.


Helio Health Investors

Investors in Helio Health by funding rounds participated
InvestorHQRoundsRoleFirst check

This data is available for Pro users. Sign up to see all 2 Helio Health investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Helio Health Competitors

Helio Health competitors include listed companies like Roche, Illumina, Tempus AI and iFlytek, and private ones like SambaNova and Quantum Systems.

Public and private companies comparable to Helio Health
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
RocheSwitzerlandSwitzerlandPublicly listed$77B$26B$351B4.9x
IlluminaUnited StatesUnited StatesPublicly listed$4.3B$1.4B$37B8.4x
Tempus AIUnited StatesUnited StatesPublicly listed$1.3B($131M)$15B10.1x
iFlytekChinaChinaPublicly listed$4B$465M$14B3.4x
SambaNovaUnited StatesSan Francisco, CAPrivate$100M-$11B-
Quantum SystemsGermanyGilchingPrivate$330M-$8B24.2x

Helio Health Public Comps

Helio Health is still privately-owned, but its public comps include Samsung, Johnson & Johnson, Roche, CrowdStrike, SAP, Thermo Fisher Scientific, Siemens, Salesforce, Abbott and Danaher.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Samsung$243B$67B4.4x2.4x15.8x4.4x
Johnson & Johnson$94B$40B7.2x6.8x17.0x18.3x
Roche$77B$26B5.0x4.9x14.6x12.4x
CrowdStrike$4.8B($12M)51.4x44.5x(19816.2x)151.0x
SAP$42B$13B5.8x5.4x18.4x17.1x
Thermo Fisher Scientific$45B$11B6.3x6.0x26.8x23.6x
Siemens$91B$15B3.0x2.9x18.1x15.7x
Salesforce$42B$13B5.5x5.2x17.8x12.2x

This data is available for Pro users. Sign up to see all Helio Health competitors and their valuation data.

Start Free Trial

Common questions about Helio Health

When was Helio Health founded?Helio Health was founded in 2014.
Where is Helio Health headquartered?Helio Health is headquartered in Los Angeles, CA, United States.
Is Helio Health publicly listed?No, Helio Health is a private, VC-backed company.
How much funding has Helio Health raised?Helio Health has raised $148M across 2 funding rounds.
What was Helio Health's last funding round?Helio Health's last funding round was a $118M Series B in July 2021, led by Fulgent Genetics and Samsung Securities.
Who are Helio Health's investors?Helio Health's investors include Fulgent Genetics and Samsung Securities.
Which companies are comparable to Helio Health?Companies comparable to Helio Health include Roche, Illumina, Tempus AI, iFlytek, SambaNova and Quantum Systems.

See companies similar to Helio Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial